I am Chief of Molecular Pathology, Director of the Biospecimen Repository and Histopathology Service at Rutgers Cancer Institute, and a physician scientist. I completed a combined MD/PhD degree at Wake Forest University School of Medicine, pathology residency at the National Cancer Institute, and one fellowship in molecular genetic pathology at the University of Pittsburgh Medical Center. Additionally, I am fellowship trained in pathology informatics from Harvard Medical School, I have been at Rutgers since completing fellowship training in 2015. My clinical responsibilities include sign-out of all molecular oncology cases generated at Rutgers Robert Wood Johnson University Hospital. I lead the Precision Medicine Initiative at Rutgers Cancer Institute and present and make treatment recommendations based on genomic profiling of tumors at a weekly molecular tumor board. These treatment recommendations include clinical trials and off-label therapies, in addition to FDA approved agents, based on the tumor’s underlying molecular alterations and histologic subtype.